novel laboratory-based therapeutic approach in al amyloidosis: investigating flc secretion
Published 9 months ago • 132 plays • Length 1:53Download video MP4
Download video MP3
Similar videos
-
3:01
novel promising agents and clinical trials in amyloidosis
-
1:17
novel treatment approaches being explored in amyloidosis: immunotherapeutic agents & venetoclax
-
5:16
the evolution of al amyloidosis therapy
-
3:23
novel agents and clinical trials emerging for the treatment of al amyloidosis
-
1:03
real-world management of patients with al amyloidosis
-
9:53
key highlights in amyloidosis at ash 2023: diagnosis & novel immunotherapeutic agents being explored
-
0:52
how novel technologies and machine learning are impacting drug research in amyloidosis
-
1:51
thrombotic and bleeding complications in al amyloidosis
-
48:26
novel technologies for immunotherapy by dr. james moon
-
51:36
bringing novel biomarkers from research to clinical use
-
2:34
novel approaches for identifying bacteria
-
0:57
novel therapeutic strategies in all
-
1:45
role for mrd assessment in al amyloidosis?
-
5:07
daratumumab in the management of al amyloidosis
-
4:01
al amyloidosis: multidisciplinary treatment approach
-
2:56
early vs. deferred transplantation in al amyloidosis
-
1:45
real-world data in guiding amyloidosis treatment
-
3:15
goal of therapy in al amyloidosis: what predicts the best outcome?
-
5:00
diagnosing and treating al amyloidosis: a 2020 update from dr morie gertz
-
12:03
how will novel agents affect the amyloidosis population?
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
1:02
maintenance therapy following treatment for amyloidosis